Loading company…
Riskpilot
← Back to search
Sign in
Get full access
JMVA Biotech AB
AB
Active
Org 5590439567
Luxgatan 9 Lagenhet 1002
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2015
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1,3M
-8% vs 2023
EBITDA margin
40.5%
-28% vs 2023
Equity ratio
88.2%
Financial strength
Net profit 2024
SEK 426K
-30% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2020
0M
-100%
2021
0M
0%
2022
1M
+100%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 1,3M
-8%
EBITDA
SEK 507K
-28%
Net profit
SEK 426K
-30%
Total assets
SEK 2,4M
+10%
Equity
SEK 2,2M
+12%
Employees
1
—
Company information
Legal name
JMVA Biotech AB
Org number
5590439567
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
22 december 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utföra konsultationer inom bioteknisk forskning och utveckling och därmed förenlig verksamhet.
Contact
Address
Luxgatan 9 Lagenhet 1002
Email
jim.vanalstine@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
1M
2023
1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 886
1 292
1 290
1 367
1 252
Staff expenses
—
−733
−631
−442
−595
EBITDA
794
219
359
707
507
Depreciation & amort.
−0
—
—
—
—
EBIT
794
219
359
707
507
Net financials
—
−0
2
32
33
Profit before tax
794
219
362
774
540
Tax
−172
−46
−77
−167
−114
Net profit
622
173
284
607
426
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 349
2 386
2 191
2 222
2 449
Equity
2 018
1 891
1 876
1 933
2 159
Long-term debt
0
—
—
—
—
Short-term debt
30
195
15
24
25
Total debt
30
195
15
24
25
Financial ratios
5-year trend
EBITDA margin
40.5%
This company
15.8%
Market median
+156% vs market
2020
2024
Equity ratio
88.2%
This company
38.2%
Market median
+131% vs market
2020
2024
Return on equity
19.8%
This company
18.4%
Market median
+8% vs market
2020
2024
Net profit margin
34.1%
This company
8.1%
Market median
+321% vs market
2020
2024
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
2020
2024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
MM
Markus Melvin Van Alstine
Deputy Board Member
2022
JM
James Melvin Van Alstine
Board of Directors
2022
KJ
Karl Jonas Harald Köhler
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of JMVA Biotech AB also hold positions in
0
other companies.
Person
Role here
Other companies
Markus Melvin Van Alstine
Deputy Board Member
0 companies
James Melvin Van Alstine
Board of Directors
0 companies
Karl Jonas Harald Köhler
Deputy Board Member
0 companies